The Cologne, Germany-based company provides solutions for cell and therapy research, including COVID-19-related products. It has facilities in 28 countries and employs more than 3,000 people.

In an official statement, Miltenyi Biotec announced that, over the past couple of weeks, it experienced malware attacks that affected some of its order processing capabilities.

“During the last two weeks, there have been isolated cases where order processing was impaired by malware in parts of our global IT infrastructure,” the company says.